Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-20

FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA Inc.'s solifenacin succinate as an Original Application (ANDA) for a generic version of the product. Solifenacin succinate is ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (solifenacin)

Snippet

ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)